Annual EBITDA:
$9.14B-$8.04B(-46.79%)Summary
- As of today, ABBV annual EBITDA is $9.14 billion, with the most recent change of -$8.04 billion (-46.79%) on December 31, 2024.
- During the last 3 years, ABBV annual EBITDA has fallen by -$14.80 billion (-61.82%).
- ABBV annual EBITDA is now -62.20% below its all-time high of $24.17 billion, reached on December 31, 2022.
Performance
ABBV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$6.67B-$1.22B(-15.41%)Summary
- As of today, ABBV quarterly EBITDA is $6.67 billion, with the most recent change of -$1.22 billion (-15.41%) on September 30, 2025.
- Over the past year, ABBV quarterly EBITDA has increased by +$618.00 million (+10.21%).
- ABBV quarterly EBITDA is now -19.08% below its all-time high of $8.24 billion, reached on December 31, 2022.
Performance
ABBV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$27.37B+$618.00M(+2.31%)Summary
- As of today, ABBV TTM EBITDA is $27.37 billion, with the most recent change of +$618.00 million (+2.31%) on September 30, 2025.
- Over the past year, ABBV TTM EBITDA has increased by +$2.04 billion (+8.07%).
- ABBV TTM EBITDA is now -13.86% below its all-time high of $31.77 billion, reached on March 31, 2023.
Performance
ABBV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABBV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -46.8% | +10.2% | +8.1% |
| 3Y3 Years | -61.8% | -16.7% | -8.8% |
| 5Y5 Years | -25.3% | +14.8% | +47.9% |
ABBV EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -62.2% | at low | -19.1% | +31.8% | -13.9% | +9.6% |
| 5Y | 5-Year | -62.2% | at low | -19.1% | +31.8% | -13.9% | +47.9% |
| All-Time | All-Time | -62.2% | +154.9% | -19.1% | +1647.0% | -13.9% | +2132.5% |
ABBV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $6.67B(-15.4%) | $27.37B(+2.3%) |
| Jun 2025 | - | $7.89B(+30.6%) | $26.75B(+3.1%) |
| Mar 2025 | - | $6.04B(-10.9%) | $25.94B(+3.9%) |
| Dec 2024 | $9.14B(-46.8%) | $6.78B(+11.9%) | $24.97B(-1.4%) |
| Sep 2024 | - | $6.05B(-14.5%) | $25.32B(-2.6%) |
| Jun 2024 | - | $7.08B(+39.8%) | $26.01B(+0.1%) |
| Mar 2024 | - | $5.06B(-29.0%) | $25.97B(-9.8%) |
| Dec 2023 | $17.17B(-29.0%) | $7.13B(+5.8%) | $28.81B(-3.7%) |
| Sep 2023 | - | $6.74B(-4.3%) | $29.92B(-4.1%) |
| Jun 2023 | - | $7.04B(-10.9%) | $31.20B(-1.8%) |
| Mar 2023 | - | $7.90B(-4.2%) | $31.77B(+2.7%) |
| Dec 2022 | $24.17B(+1.0%) | $8.24B(+2.9%) | $30.94B(+3.2%) |
| Sep 2022 | - | $8.01B(+5.2%) | $29.99B(+1.6%) |
| Jun 2022 | - | $7.62B(+7.7%) | $29.51B(+2.7%) |
| Mar 2022 | - | $7.07B(-3.0%) | $28.72B(+1.8%) |
| Dec 2021 | $23.93B(+94.2%) | $7.29B(-3.2%) | $28.23B(+2.6%) |
| Sep 2021 | - | $7.53B(+10.3%) | $27.51B(+6.7%) |
| Jun 2021 | - | $6.83B(+3.8%) | $25.79B(+9.8%) |
| Mar 2021 | - | $6.58B(0.0%) | $23.50B(+11.4%) |
| Dec 2020 | $12.32B(+0.8%) | $6.58B(+13.2%) | $21.10B(+14.0%) |
| Sep 2020 | - | $5.81B(+28.2%) | $18.50B(+9.8%) |
| Jun 2020 | - | $4.53B(+8.5%) | $16.85B(+3.3%) |
| Mar 2020 | - | $4.18B(+4.9%) | $16.32B(+2.4%) |
| Dec 2019 | $12.23B(+47.1%) | $3.98B(-4.2%) | $15.93B(+3.5%) |
| Sep 2019 | - | $4.16B(+3.9%) | $15.39B(+2.9%) |
| Jun 2019 | - | $4.00B(+5.4%) | $14.96B(+5.3%) |
| Mar 2019 | - | $3.79B(+10.2%) | $14.21B(+1.4%) |
| Dec 2018 | $8.31B | $3.44B(-7.6%) | $14.02B(+4.4%) |
| Sep 2018 | - | $3.73B(+14.5%) | $13.43B(+5.4%) |
| Jun 2018 | - | $3.25B(-9.7%) | $12.75B(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $3.60B(+26.3%) | $12.62B(+6.8%) |
| Dec 2017 | $10.38B(+2.5%) | $2.85B(-6.2%) | $11.81B(+0.9%) |
| Sep 2017 | - | $3.04B(-2.7%) | $11.71B(+2.1%) |
| Jun 2017 | - | $3.13B(+12.0%) | $11.47B(+2.8%) |
| Mar 2017 | - | $2.79B(+1.6%) | $11.16B(+1.7%) |
| Dec 2016 | $10.12B(+23.4%) | $2.75B(-1.9%) | $10.97B(+2.8%) |
| Sep 2016 | - | $2.80B(-0.6%) | $10.67B(+6.3%) |
| Jun 2016 | - | $2.82B(+8.3%) | $10.04B(+3.9%) |
| Mar 2016 | - | $2.60B(+6.2%) | $9.66B(+6.0%) |
| Dec 2015 | $8.20B(+128.8%) | $2.45B(+13.2%) | $9.11B(+9.8%) |
| Sep 2015 | - | $2.17B(-11.3%) | $8.30B(+6.8%) |
| Jun 2015 | - | $2.44B(+18.8%) | $7.77B(+7.9%) |
| Mar 2015 | - | $2.05B(+25.6%) | $7.20B(+6.0%) |
| Dec 2014 | $3.58B(-45.1%) | $1.64B(0.0%) | $6.79B(-3.6%) |
| Sep 2014 | - | $1.64B(-12.6%) | $7.04B(-3.5%) |
| Jun 2014 | - | $1.87B(+13.9%) | $7.29B(-0.2%) |
| Mar 2014 | - | $1.64B(-13.0%) | $7.31B(+1.0%) |
| Dec 2013 | $6.53B(-6.5%) | $1.89B(+0.1%) | $7.24B(-5.1%) |
| Sep 2013 | - | $1.89B(+0.3%) | $7.63B(-2.0%) |
| Jun 2013 | - | $1.88B(+19.6%) | $7.79B(-0.2%) |
| Mar 2013 | - | $1.57B(-30.9%) | $7.80B(+0.2%) |
| Dec 2012 | $6.98B(+41.3%) | $2.28B(+11.4%) | $7.79B(+1.6%) |
| Sep 2012 | - | $2.05B(+7.7%) | $7.67B(+27.7%) |
| Jun 2012 | - | $1.90B(+21.6%) | $6.00B(+0.7%) |
| Mar 2012 | - | $1.56B(-27.7%) | $5.96B(+6.0%) |
| Dec 2011 | $4.94B(-17.9%) | $2.16B(+465.6%) | $5.63B(+62.3%) |
| Sep 2011 | - | $381.85M(-79.5%) | $3.47B(+12.4%) |
| Jun 2011 | - | $1.86B(+51.6%) | $3.08B(+151.6%) |
| Mar 2011 | - | $1.23B | $1.23B |
| Dec 2010 | $6.02B(+3.8%) | - | - |
| Dec 2009 | $5.80B | - | - |
FAQ
- What is AbbVie Inc. annual EBITDA?
- What is the all-time high annual EBITDA for AbbVie Inc.?
- What is AbbVie Inc. annual EBITDA year-on-year change?
- What is AbbVie Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for AbbVie Inc.?
- What is AbbVie Inc. quarterly EBITDA year-on-year change?
- What is AbbVie Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for AbbVie Inc.?
- What is AbbVie Inc. TTM EBITDA year-on-year change?
What is AbbVie Inc. annual EBITDA?
The current annual EBITDA of ABBV is $9.14B
What is the all-time high annual EBITDA for AbbVie Inc.?
AbbVie Inc. all-time high annual EBITDA is $24.17B
What is AbbVie Inc. annual EBITDA year-on-year change?
Over the past year, ABBV annual EBITDA has changed by -$8.04B (-46.79%)
What is AbbVie Inc. quarterly EBITDA?
The current quarterly EBITDA of ABBV is $6.67B
What is the all-time high quarterly EBITDA for AbbVie Inc.?
AbbVie Inc. all-time high quarterly EBITDA is $8.24B
What is AbbVie Inc. quarterly EBITDA year-on-year change?
Over the past year, ABBV quarterly EBITDA has changed by +$618.00M (+10.21%)
What is AbbVie Inc. TTM EBITDA?
The current TTM EBITDA of ABBV is $27.37B
What is the all-time high TTM EBITDA for AbbVie Inc.?
AbbVie Inc. all-time high TTM EBITDA is $31.77B
What is AbbVie Inc. TTM EBITDA year-on-year change?
Over the past year, ABBV TTM EBITDA has changed by +$2.04B (+8.07%)